Buchler GmbH
  • Products
    • Active Pharmaceutical Ingredients
    • Asymmetric Synthesis
      • Chiral Building Blocks
      • Chiral Phase Transfer Catalysts (PTCs)
      • Chiral Screening Kit
      • Enantioselective Organocatalysts
      • Racemic Resolution
    • Food Ingredients
    • Product Overview
  • Chiral Catalyst Search (NEW)
  • Contact
  • About
    • Certificates
    • Company Policy
    • Former Buchler Company Managers
    • Galleries
      • Gallery current production and storage
      • Gallery Laboratory
      • Gallery Historical Production
    • History of Buchler
  • Career
Select Page

Spirocyclization (Sulfa-Michael Aldol-Cascade), 1,4-dithiane-2,5-diol, N/C-substituted-(E)-[3,3′-biindolinylidene]-2,2′-dione, N/C-substituted-(3S,3’R,4’R)-4′-hydroxy-4′,5′-dihydrodispiro[indoline-3,2′-thiophene-3′,3”-indoline]-2,2”-dione, Quinine Base

by werner@buchler-gmbh.com | Feb 21, 2023

Amination, 4-substituted-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one, disubstituted-(E)-diazene-1,2-dicarboxylate, (1-(4-substituted-3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)hydrazine-1,2-diyl)bis((substituted)oxy)methanone), Quinine Base

by werner@buchler-gmbh.com | Feb 16, 2023

Michael Addition, ethyl 2-nitropropanoate, nitro olefins, ethyl (2R)-3-substituted-2-methyl-2,4-dinitrobutanoates, (8α,9R)-(8′′α,9′′R)-9,9′′-[1,4-Phthalazinediylbis (oxy)]bis[10,11-dihydrocinchonan-6′-ol, Dihydrocupreine Derivative

by Anna-Lena Hartmann | Nov 30, 2022

Transamination, 4-(2-bromophenyl)-1,1,1-trifluorobutan-2-one, 4-(aminomethyl)-3-chlorobenzonitrile, (R)-4-(2-bromophenyl)-1,1,1-trifluorobutan-2-amine, (8α,9R)-N-[2,6-Bis(1-methylethyl)-4-nitrophenyl]-9-[3-[2,4,6-tris(1-methylethyl)phenyl]propoxy]-Cinchonan-6′-amine, 6´-Aminocinchonidine Derivative

by Anna-Lena Hartmann | Nov 29, 2022

Iodination, (E)-3-(4-chlorophenyl)-1-phenylbut-3-en-1-one oxime, 1-iodopyrrolidine-2,5-dione, (S)-5-(4-chlorophenyl)-5-(iodomethyl)-3-phenyl-4,5-dihydroisoxazole, N-[3,5-Bis(trifluoromethyl)phenyl]-N′-[(8α,9S)-10,11-dihydrocinchonan-9-yl]thiourea, Dihydrocinchonidine Derivative

by Anna-Lena Hartmann | Nov 3, 2022

« Older Entries
Next Entries »

Glossary

Impressum / Legal Notice

Code of Conduct

Hinweisgebersystem / Whistleblowing System

Allgemeine Geschäfts-bedingungen / General Terms and Conditions

Datenschutzhinweise / Data Protection Information

Contact

My Account
  • Follow
  • Follow

All Rights Reserved by Buchler GmbH